FSFatima Sfifou

Fatima Sfifou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatima Sfifou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Abderrahmane Al Bouzidi

    Research's Pedagogic Unit of Pathological Anatomy, Laboratory of Pathological Anatomy, Research Team in Tumour Pathology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco

    2 shared publications
  • Abdessamad El Ouahabi

    Neurosurgery Department, Hospital of Specialities in Rabat, Morocco

    2 shared publications
  • El Mehdi Hakkou

    Neurosurgery Department, Hospital of Specialities in Rabat, Morocco

    2 shared publications
  • Hassan Errihani

    National Oncology Centre Sidi Mohamed Ben Abdallah in Rabat, Morocco

    2 shared publications
  • Nadia Cherradi

    Research's Pedagogic Unit of Pathological Anatomy, Laboratory of Pathological Anatomy, Research Team in Tumour Pathology, Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco; Pathological Anatomy Department, Hospital of Specialities in Rabat, Morocco

    2 shared publications
  • Redouane Abouqal

    Laboratory of Biostatistics, Clinical Research and Epidemiology, Rabat Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Morocco

    2 shared publications

Latest Publications

  • Immunohistochemical expression of HIF-1α, IDH1 and TP53: Prognostic profile of Moroccan patients with diffuse glioma

    by Fatima Sfifou, Mounir Ouzir, El Mehdi Hakkou, Majdouline Obtel, Hassan Errihani, Abderrahmane Al Bouzidi, Redouane Abouqal, Abdessamad El Ouahabi, Nadia Cherradi


  • Open Access

    Correlation of immunohistochemical expression of HIF-1alpha and IDH1 with clinicopathological and therapeutic data of moroccan glioblastoma and survival analysis

    by Fatima Sfifou, El Mehdi Hakkou, Arbi EL Bouaiti, Meriem Slaoui, Hassan Errihani, Abderrahmane Al Bouzidi, Redouane Abouqal, Abdessamad El Ouahabi, Nadia Cherradi

    Introduction: Glioblastomas are aggressive primary intracranial tumours of the central nervous system causing significant mortality and morbidity worldwide. Objective: This study aims to evaluate the prognostic value of tissue expression by immunostaining of hypoxiainducible factor (HIF-1 alpha), isocitrate dehydrogenase 1 (IDH1), and tumour protein p53 in glioblastoma in Moroccan patients. The association of HIF-1 alpha, IDH1, and p53 expression with the clinicopathological data and overall patient survival (OS) was also evaluated. Materials and methods: Confirmed glioblastomas were included in this study. Twenty-two tissue samples were obtained by neurosurgical intervention resulting from total resection, and subtotal resection or biopsy. Karnofsky index, histological type of tumour, and the status of IDH1, p53 protein, and HIF-1 alpha expression by immunostaining were reported. Results: The majority of the patients were males (64%) with a sex ratio of 1.75. The average age was 54 +/- 13. Median follow-up was 10.10 months and median overall survival was 10 months. The expression of HIF-1 alpha was high in 10 samples (45%) and low in 12 (55%). There was a statistically significant difference in OS of 85% at 12 months for the subgroup of patients "HIF-1 alpha negative IDH1 positive" p = 0.038, the unadjusted analysis showed that the group "HIF-1 alpha positive, IDH1 positive" was a poor prognostic factor, the HR was 0.08 (95% CI: 0.009-0.756, p = 0.027). Conclusion: Patients with negative HIF-1 alpha expression and positive IDH1 expression have a better prognosis, suggesting that these two biomarkers may be useful in the search for new approaches for targeted therapy in glioblastoma.